en
Feedback
Marrow Notes

Marrow Notes

Open in Telegram

📈 Analytical overview of Telegram channel Marrow Notes

Channel Marrow Notes (@marrow_edition9notes) in the English language segment is an active participant. Currently, the community unites 125 095 subscribers, ranking 79 in the Medicine category and 1 844 in the India region.

📊 Audience metrics and dynamics

Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 125 095 subscribers.

According to the latest data from 27 August, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by -78 over the last 30 days and by 1 over the last 24 hours, overall reach remains high.

  • Verification status: Not verified
  • Engagement rate (ER): The average audience engagement rate is 0%. Within the first 24 hours after publication, content typically collects N/A% reactions from the total number of subscribers.
  • Post reach: On average, each post receives 0 views. Within the first day, a publication typically gains 0 views.
  • Reactions and interaction: The audience actively supports content: the average number of reactions per post is 0.

📝 Description and content policy

Channel description not provided.

Thanks to the high frequency of updates (latest data received on 28 August, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.

125 095
Subscribers
+124 hours
-1007 days
-7830 days

Data loading in progress...

Similar Channels
No data
Any problems? Please refresh the page or contact our support manager.
Tags Cloud
No data
Any problems? Please refresh the page or contact our support manager.
Incoming and Outgoing Mentions
---
---
---
---
---
---
Attracting Subscribers
August '26
August '26
+155
in 0 channels
July '26
+361
in 0 channels
Get PRO
June '26
+130
in 0 channels
Get PRO
May '26
+308
in 0 channels
Get PRO
April '26
+471
in 2 channels
Get PRO
March '26
+411
in 0 channels
Get PRO
February '26
+1 205
in 0 channels
Get PRO
January '26
+1 453
in 0 channels
Get PRO
December '25
+1 214
in 1 channels
Get PRO
November '25
+1 003
in 0 channels
Get PRO
October '250
in 0 channels
Get PRO
September '250
in 0 channels
Get PRO
August '250
in 0 channels
Get PRO
July '250
in 0 channels
Get PRO
June '250
in 0 channels
Get PRO
May '250
in 0 channels
Get PRO
April '25
+1
in 0 channels
Get PRO
March '25
+1
in 0 channels
Get PRO
February '250
in 0 channels
Get PRO
January '250
in 0 channels
Get PRO
December '240
in 0 channels
Get PRO
November '240
in 0 channels
Get PRO
October '240
in 0 channels
Get PRO
September '24
+1 477
in 0 channels
Get PRO
August '24
+1 441
in 0 channels
Get PRO
July '24
+1 735
in 0 channels
Get PRO
June '24
+1 849
in 0 channels
Get PRO
May '24
+3 870
in 0 channels
Get PRO
April '240
in 0 channels
Get PRO
March '24
+2 024
in 0 channels
Get PRO
February '24
+1 241
in 0 channels
Get PRO
January '24
+1 364
in 0 channels
Get PRO
December '23
+13 105
in 0 channels
Get PRO
November '230
in 0 channels
Get PRO
October '230
in 0 channels
Get PRO
September '230
in 0 channels
Get PRO
August '230
in 0 channels
Get PRO
July '230
in 0 channels
Get PRO
June '230
in 0 channels
Get PRO
May '230
in 0 channels
Get PRO
April '230
in 0 channels
Get PRO
March '23
+3 881
in 0 channels
Get PRO
February '230
in 0 channels
Get PRO
January '230
in 0 channels
Get PRO
December '22
+1 482
in 0 channels
Get PRO
November '22
+1 805
in 0 channels
Get PRO
October '22
+1 736
in 0 channels
Get PRO
September '22
+3 416
in 0 channels
Get PRO
August '22
+4 091
in 0 channels
Get PRO
July '22
+8 254
in 0 channels
Get PRO
June '22
+8 833
in 0 channels
Get PRO
May '22
+7 177
in 0 channels
Get PRO
April '22
+7 855
in 0 channels
Get PRO
March '22
+9 952
in 0 channels
Get PRO
February '22
+6 594
in 0 channels
Get PRO
January '22
+3 680
in 0 channels
Get PRO
December '21
+66
in 0 channels
Get PRO
November '21
+4 539
in 0 channels
Get PRO
October '21
+5 844
in 0 channels
Get PRO
September '21
+5 426
in 0 channels
Get PRO
August '21
+5 610
in 0 channels
Get PRO
July '21
+8 481
in 0 channels
Get PRO
June '21
+4 907
in 0 channels
Get PRO
May '21
+5 065
in 0 channels
Get PRO
April '21
+3 697
in 0 channels
Get PRO
March '21
+2 630
in 0 channels
Get PRO
February '21
+2 268
in 0 channels
Date
Subscriber Growth
Mentions
Channels
28 August+3
27 August+1
26 August+2
25 August0
24 August0
23 August0
22 August+3
21 August+3
20 August0
19 August+8
18 August+5
17 August+4
16 August+6
15 August+4
14 August+7
13 August+6
12 August+6
11 August0
10 August+6
09 August+3
08 August+8
07 August+10
06 August+11
05 August+31
04 August+3
03 August0
02 August+20
01 August+5
Channel Posts
Malignant testicular neoplasms Type Features Germ cell (95%)Seminoma• Retain features of spermatogenesis • β-hCG, AFP usually negative Nonseminoma• ≥1 partially differentiated cells: yolk sac, embryonal carcinoma, teratoma, and/or choriocarcinoma • β-hCG, AFP usually positive Stromal (5%)Leydig• Often produces excessive estrogen (gynecomastia) or testosterone (acne) • Can cause precocious puberty Sertoli• Rare • Occasionally associated with excessive estrogen secretion (eg, gynecomastia) AFP = alpha-fetoprotein. This patient with a testicular mass, gynecomastia, and elevated estrogen levels likely has a Leydig cell tumor, the most common type of testicular sex cord stromal tumor. These tumors arise from supporting cells of the testis such as Leydig, Sertoli, and granulosa cells; they account for approximately 5% of testicular tumors (germ cell tumors account for ~95%), arise in a wide range of ages, and have no clearly defined risk factors. Leydig cells are the primary source of testicular testosterone but are also capable of generating estrogen. Therefore, Leydig cell tumors often present with endocrine manifestations due to excessive estrogen (eg, gynecomastia, loss of libido, erectile dysfunction) or testosterone (eg, acne, hirsutism). Examination frequently reveals a testicular mass, which is typically confirmed by bilateral scrotal ultrasound. In contrast to many germ cell tumors, Leydig cells do not generally produce serum tumor markers such as β-hCG or alpha-fetoprotein (AFP). However, the generation of estrogen or testosterone often leads to FSH and LH suppression. (Choices A, D, and E) Choriocarcinoma, teratoma, and yolk sac tumors are nonseminomatous germ cell tumors. They typically present with a painless, firm testicular mass. However, they often produce β-hCG (particularly choriocarcinoma) or AFP (particularly yolk sac tumors) in addition; estrogen production is rare, so feminization is uncommon. (Choice C) Seminoma is a germ cell tumor that does not usually produce β-hCG, AFP, or estrogen. Therefore, feminization would be atypical. Most seminomas present with a painless, unilateral testicular mass or swelling. TAKE HOME MESSAGE Leydig cell testicular tumors often cause feminization (eg, gynecomastia) due to the production of estrogen by tumor cells. This frequently causes secondary inhibition of FSH and LH. Serum tumor markers (eg, β-hCG, AFP) are not usually elevated.

2
Which of the following is the most likely diagnosis in this patient? #NEETPG #INICET
30 001
3
A 35-year-old man comes to the office due to a progressive increase in breast size over the past 6 months. He is sexually active, has no chronic medical conditions, and takes no medications. The patient does not use tobacco, alcohol, or illicit drugs. Vital signs are normal. BMI is 28 kg/m². Gynecomastia with mild bilateral breast tenderness is present. Genitourinary examination reveals a 1-cm nodule in the right testis. The examination is otherwise normal. Laboratory results are as follows: LH: 3 U/L (normal: 6–23 U/L) FSH: 2 U/L (normal: 4–25 U/L) Testosterone: 270 ng/dL (normal: 300–1,000 ng/dL) Estradiol: 115 pg/mL (normal: 20–60 pg/mL) β-hCG: undetectable Alpha-fetoprotein: undetectable
28 384
4
Join PROFWISE MBBS Groups! 1. 1st PROF MBBS: https://t.me/+rMA2Sew_gp41MDk1 2. 2nd PROF MBBS: https://t.me/+SD0oh2UMHAFmNjM1 3. 3rd PROF MBBS: https://t.me/+yxj_Ruzm37o0MDY1 4. FINAL PROF MBBS: https://t.me/+WQnwlzhiBU1hMTc1 5. FMGE (Abroad MBBS): https://t.me/FMGEgroupstudents 6. NEET PG/INICET (Interns/Post-interns): https://t.me/+TfvNbL3UWlw1NWI1 7. NEET SS/INI SS (Residents): https://t.me/Neet_SS Join respective group only! ⚠️ Queries: https://t.me/murtazakuchay (@murtazakuchay) 💬
1
5
FEW HOURS LEFT FOR HOURS 📅 *Version XI ELITE Plan* is still available at Flat 40% OFF 📉 — buy by today 11;59 pm this price
FEW HOURS LEFT FOR HOURS 📅 *Version XI ELITE Plan* is still available at Flat 40% OFF 📉 — buy by today 11;59 pm this price is history. *Register for Discount* 👉: https://prepladder.com/app/resolve-live-classes-381--DCTRXNSQ Till Neet PG Plan- *₹7899* 💰 12 months *17499* 🗓️ 16 months *21499* 24 months *25499* 36 months *30999* 48 months *34999* ☮️ Use Best Code: *DCTRXNSQ* 🎟️ *Register Offer Link* : https://prepladder.com/app/resolve-live-classes-381--DCTRXNSQ Max Discount: DCTRXNSQ 🏷️ Join group offer https://chat.whatsapp.com/FdIInMlLAOeFl2kvg2xhT8?mode=gi_t
2 922
6
Tomorrow is where hesitation gets expensive. 😵‍💫⏳ *Version XI ELITE Plan is still available at Flat 40% OFF* — but by tomor
Tomorrow is where hesitation gets expensive. 😵‍💫⏳ *Version XI ELITE Plan is still available at Flat 40% OFF* — but by tomorrow, this price is history. *Register for Discount* 👉: https://prepladder.com/app/resolve-live-classes-381--DCTRXNSQ Till Neet PG Plan- *₹7899* 12 months *17499* 16 months *21499* 24 months *25499* 36 months *30999* 48 months *34999* ☮️ Use Best Code: *DCTRXNSQ* *Register Offer Link* : https://prepladder.com/app/resolve-live-classes-381--DCTRXNSQ Max Discount: *DCTRXNSQ* *Dm Quick and get check that you avail all the possible discount.*
6 234
7
FREE PREPLADDER RAPID REVISION For the next 3 days free access, you can step inside *Rapid Revision* *Click on the link below
FREE PREPLADDER RAPID REVISION For the next 3 days free access, you can step inside *Rapid Revision* *Click on the link below to register FREE 🆓👇* https://prepladder.com/app/rapid-revision-XI-videos-391--DCTRXNSQ Max Discount code: *DCTRXNSQ* ⚡ High-yield video lectures ⚡ Every topic tagged with PYQs from NEET PG, FMGE & INI-CET 😱 *DON'T FORGET TO CLICK THE LINK FOR FREE ACCESS* 👇 https://prepladder.com/app/rapid-revision-XI-videos-391--DCTRXNSQ Best discount code: *DCTRXNSQ* _This is your chance to experience Rapid Revision before the real deal begins_
6 835
8
Proper breastfeeding technique promotes maternal comfort, ensures adequate infant nutritional intake, and facilitates long-term breastfeeding. Most breastfeeding patients experience nipple pain in the immediate postpartum period as they become accustomed to nursing 8-12 times/day or more, but this typically resolves after a few weeks. Nipple pain that worsens and persists between feedings is commonly due to nipple injury caused by poor infant positioning and improper latch-on technique. On examination, patients can have open, linear areolar abrasions that cause a bloody-appearing nipple discharge, bruising, cracking, and blistering may also be present. Breast engorgement, as seen in this patient with bilateral, diffusely tender, and engorged breasts, can also develop because nipple pain limits breastfeeding. Initial management is with the observation of breastfeeding and patient education. Nipple injury is a significant risk factor for multiple adverse outcomes (eg, plugged milk ducts, mastitis, breast abscess), which often lead to premature cessation of breastfeeding. (Choice A) Lactational mastitis is caused by bacterial overgrowth of stagnant milk in blocked ducts; it is a common cause of breast pain in breastfeeding patients. In contrast to this patient, those with lactational mastitis typically have fever and localized warmth or erythema over a single breast. (Choice B) Candida mastitis can be caused by spread from infant oral flora. Patients typically have nipple pain that radiates across the breast with latching; however, the pain is described as sharp and shooting and is usually out of proportion to the examination. In addition, it is typically unilateral, and the affected breast often has flaky, scaling skin over the nipple. (Choice C) Inflammatory breast cancer can cause unilateral, not bilateral, breast pain and tenderness. Patients typically have a breast mass with associated skin thickening and erythema (peau d'orange appearance) with axillary lymphadenopathy, which is not seen in this patient. (Choice D) An intraductal papilloma, a papillary tumor involving the breast duct, typically presents with bloody nipple discharge but no associated breast pain. TAKE HOME POINT Persistent nipple pain with breastfeeding is typically due to nipple injury, which can present with bilateral nipple abrasions and bloody nipple discharge. The most common underlying causes are poor infant positioning and improper latch-on technique.
34 423
9
Which of the following is the most likely underlying cause of this patient's presentation? #INICET26 #NEETPG26
34 337
10
A 39-year-old woman, gravida 1 para 1, comes to the office due to breast pain. She had an uncomplicated vaginal delivery a week ago and is breastfeeding her infant. Four days ago, the patient began to have bilateral nipple soreness with breastfeeding. However, for the past few days, the pain has worsened, is present between feeds, and has prevented breastfeeding. She has also developed bloody nipple discharge. The patient's pregnancy was complicated by gestational diabetes mellitus, but otherwise, she has no chronic medical conditions. Temperature is 37.5 C (99.5 F). Bilateral nipples and areolae have open, bloody, linear abrasions. The breasts are diffusely engorged and mildly tender to palpation, but there are no palpable masses or lymphadenopathy. The remainder of the examination is unremarkable.
34 311
11
10% off on Teachers Day on Cerebellum packs Use code SAVE10
10% off on Teachers Day on Cerebellum packs Use code SAVE10
4 581
12
Out Toppers have Nailed it, Now it's your Time ⏳ 🔥 Offer is live 🔥 Discount code for Prepladder any Fresh/Extension plan is+1
Out Toppers have Nailed it, Now it's your Time ⏳ 🔥 Offer is live 🔥 Discount code for Prepladder any Fresh/Extension plan is DCTRXNSQ Code: DCTRXNSQ To buy any Package Apply Code directly in Prepladder app or click on the link 👇 https://www.prepladder.com/app/isa-bd-code--DCTRXNSQ
6 274
13
No text...
0
14
ALL THE BEST everyone whosoever is appearing in exams Tommorow hope u will succeed in ur mission
9 130
15
https://t.me/Medflix_200
8 316
16
No text...
0
17
No text...
0
18
Join the NextGen USMLE Renal Bootcamp for USMLE Step 1 starting June 14 (Saturday). Led by Muaz MD, a high scorer with a USML
Join the NextGen USMLE Renal Bootcamp for USMLE Step 1 starting June 14 (Saturday). Led by Muaz MD, a high scorer with a USMLE Step 2 CK score of 276. This 3-day intensive session focuses on high-yield renal concepts. Includes interactive revision and assessment at the end of the bootcamp. https://chat.whatsapp.com/CrOjgR4xK5ZDFfbeieuhCQ
2 461
19
last 1 hour left buy now use code DCTRXNSQ
2 836
20
40% off on PREPLADDER ends Today Discount is DCTRXNSQ Copy DCTRXNSQ and paste it in App grab it NOW
40% off on PREPLADDER ends Today Discount is DCTRXNSQ Copy DCTRXNSQ and paste it in App grab it NOW
4 881